Mestag Therapeutics
Immunotherapy revolutionizes cancer treatment.
What is the issue to solve?
Addressing limitations in cancer and inflammatory disease treatments through immunotherapy.
What’s their solution?
Developing therapies that target specific immune cells and checkpoints to improve outcomes for cancer and inflammatory diseases.
Who is their product for?
Oncologists, hematologists, and pharmaceutical companies are the main target audience.
Competitors
AI Disclaimer
We have generated these company profiles using AI and feeding it the companies website. Because of that we cannot guarantee the accuracy and we welcome any feedback, we will promptly change any inaccuracies.
Thank you!